Christopher Ogden

Insider Reports History

Location
South San Francisco, CA
Signature
/s/ Christopher Ogden
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christopher Ogden:

Company Role Class Num Shares Value Price $ Report Date Ownership
CytomX Therapeutics, Inc. Chief Financial Officer Common Stock 226,271 $608,420 $2.69 16 Jun 2025 Direct
CytomX Therapeutics, Inc. Chief Financial Officer Performance Stock Units (PSUs) 39,150 $0 $1.23 26 Sep 2025 Direct
CytomX Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 78,250 26 Sep 2025 Direct
CytomX Therapeutics, Inc. Chief Financial Officer Performance Stock Units 0 13 Jun 2025 Direct

Insider Reports Filed by Christopher Ogden

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CTMX CytomX Therapeutics, Inc. 26 Sep 2025 2 $0 4 Chief Financial Officer 30 Sep 2025, 18:38
CTMX CytomX Therapeutics, Inc. 13 Jun 2025 4 -$33,381 4 Chief Financial Officer 17 Jun 2025, 16:11
CTMX CytomX Therapeutics, Inc. 18 Mar 2025 1 -$5,122 4 Chief Financial Officer 20 Mar 2025, 16:33
CTMX CytomX Therapeutics, Inc. 04 Feb 2025 4 $0 4 Chief Financial Officer 06 Feb 2025, 17:55
CTMX CytomX Therapeutics, Inc. 20 Aug 2024 3 -$2,439 4 Chief Financial Officer 22 Aug 2024, 17:59
CTMX CytomX Therapeutics, Inc. 12 Jun 2024 2 $0 4 Chief Financial Officer 14 Jun 2024, 16:24
CTMX CytomX Therapeutics, Inc. 19 Mar 2024 1 -$6,196 4 SVP, Finance and Accounting 21 Mar 2024, 16:38
CTMX CytomX Therapeutics, Inc. 18 Jan 2024 3 $0 4 SVP, Finance and Accounting 19 Jan 2024, 20:41
CTMX CytomX Therapeutics, Inc. 20 Dec 2023 1 -$2,747 4 SVP, Finance and Accounting 22 Dec 2023, 16:10
CTMX CytomX Therapeutics, Inc. 17 Dec 2023 2 $0 4 SVP, Finance and Accounting 19 Dec 2023, 19:58
CTMX CytomX Therapeutics, Inc. 16 Mar 2023 1 -$1,021 4 SVP, Finance and Accounting 20 Mar 2023, 18:43
CTMX CytomX Therapeutics, Inc. 02 Feb 2023 3 $0 4 SVP, Finance and Accounting 06 Feb 2023, 15:47
CTMX CytomX Therapeutics, Inc. 10 Aug 2022 2 $0 4 SVP, Finance and Accounting 12 Aug 2022, 16:59
CTMX CytomX Therapeutics, Inc. 14 Feb 2022 0 $0 3 Interim Principal Accounting Officer 09 Mar 2022, 17:06